Table 2.
Attitudes of participants toward COVID-19 vaccine and correlation with their willingness to accept vaccination
| Research content | Classification | Total N(%) | Willing to be vaccinated (%) N = 2,284 |
Unwilling to be vaccinated (%) N = 518 |
Unadjusted OR | 95%CI | P |
|---|---|---|---|---|---|---|---|
| Whether pay attention to the progress of vaccines | No | 110 (3.93) | 69 (3.02) | 41 (7.92) | 1.00 | ||
| Yes | 2,692 (96.07) | 2,215 (96.98) | 477 (92.08) | 2.76 | 1.85–4.11 | 0.0000 | |
| Degree of urgency of need for vaccine | Not urgent | 149 (5.32) | 75 (3.42) | 74 (14.29) | 1.00 | ||
| Urgent | 2,653 (94.68) | 2,209 (96.72) | 444 (85.71) | 4.91 | 3.51–6.88 | 0.0000 | |
| The most concerned aspect | Vaccine safety | 967 (34.51) | 563 (24.65) | 404 (77.99) | 1.00 | ||
| Protective efficacy of vaccine | 687 (24.52) | 656 (28.72) | 31 (5.98) | 15.19 | 0.36–22.26 | 0.0000 | |
| Vaccine price | 328 (11.71) | 311 (13.62) | 17 (3.28) | 13.13 | 7.93–21.74 | 0.0000 | |
| Expert opinion | 324 (11.56) | 303 (13.27) | 21 (4.05) | 10.35 | 6.53–16.41 | 0.0000 | |
| Other aspects | 496 (17.70) | 451 (19.75) | 45 (8.69) | 7.19 | 5.16–10.02 | 0.0000 | |
| Acceptable vaccine price (RMB). | ≤ 200 | 2,334 (83.30) | 1,879 (82.27) | 455 (87.84) | 1.00 | ||
| 201～399. | 370 (13.20) | 320 (14.01) | 50 (9.65) | 0.49 | 0.39–0.62 | 0.0000 | |
| ≥ 400 | 98 (3.50) | 85 (3.72) | 13 (2.51) | 0.45 | 0.30–0.68 | 0.0001 |
n (%), number (percentage) of participants who were willing or un willing to be vaccinated in each category; unadjusted OR, unadjusted odds ratio; 95% CI, 95% confidence interval